These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35500559)

  • 21. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
    Akhabue E; Wong M; Mehta R; Isakova T; Wolf M; Yancy C; Gutierrez OM; Carnethon M
    Am Heart J; 2022 Mar; 245():10-18. PubMed ID: 34861237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships of Blood Pressure Circadian Rhythm and Brain Natriuretic Peptide with Left Ventricular Hypertrophy in the Patients with Primary Hypertension.
    Kou HJ; Wang X; Gao DF; Dong X; Wei J; Ma R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):514-521. PubMed ID: 27825406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis.
    Cheng N; He Y; Dang A; Lv N; Wang X; Li H
    Clin Rheumatol; 2020 May; 39(5):1591-1599. PubMed ID: 31897962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic background influences cardiac phenotype in murine chronic kidney disease.
    Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
    Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice.
    Leifheit-Nestler M; Wagner MA; Richter B; Piepert C; Eitner F; Böckmann I; Vogt I; Grund A; Hille SS; Foinquinos A; Zimmer K; Thum T; Müller OJ; Haffner D
    Front Cell Dev Biol; 2021; 9():745892. PubMed ID: 34778257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF23 induces left ventricular hypertrophy.
    Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
    J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice.
    Liu T; Wen H; Li H; Xu H; Xiao N; Liu R; Chen L; Sun Y; Song L; Bai C; Ge J; Zhang Y; Chen J
    Hypertension; 2020 Mar; 75(3):680-692. PubMed ID: 31928110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yasunari K; Yokokawa K; Horio T; Kano H; Minami M; Ikeda M; Yoshikawa J
    Metabolism; 1996 Nov; 45(11):1326-9. PubMed ID: 8931634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.
    Leifheit-Nestler M; Richter B; Basaran M; Nespor J; Vogt I; Alesutan I; Voelkl J; Lang F; Heineke J; Krick S; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():333. PubMed ID: 29977226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Sala C; Sampieri L; Magrini F; Zanchetti A
    J Hypertens; 2005 Apr; 23(4):875-82. PubMed ID: 15775794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy.
    Okamoto K; Fujii H; Watanabe K; Goto S; Kono K; Nishi S
    J Endocr Soc; 2022 Feb; 6(2):bvab187. PubMed ID: 35047715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
    Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoxyl sulfate induces left ventricular hypertrophy
    Kishimoto H; Nakano T; Torisu K; Tokumoto M; Uchida Y; Yamada S; Taniguchi M; Kitazono T
    Front Cardiovasc Med; 2023; 10():990422. PubMed ID: 36895836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23.
    Matsui I; Oka T; Kusunoki Y; Mori D; Hashimoto N; Matsumoto A; Shimada K; Yamaguchi S; Kubota K; Yonemoto S; Higo T; Sakaguchi Y; Takabatake Y; Hamano T; Isaka Y
    Kidney Int; 2018 Jul; 94(1):60-71. PubMed ID: 29751971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.